{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:40:41Z","timestamp":1791430841628,"version":"4.3.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The treatment of retinoblastoma (Rb) has undergone significant improvements over the last century. This study aims to assess the trend of enucleation and mortality in retinoblastoma patients during the last 3 decades.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The study utilized data from the referral center for ocular oncology in Rasool Akram Hospital, Tehran, Iran. It included all patients diagnosed with Rb from August 1991 to December 2018. The study investigated the trend of enucleation and mortality during three-time intervals: before 2001 (T1), during 2001\u20132007 (T2), and 2008\u20132018 (T3). Additionally, it assessed the trend of enucleation and mortality based on laterality, age and presentation of Rb (strabismus and leukocoria).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The incidence of enucleation decreased significantly from T1 to T3 (74\u201341%) during the study period (p-value\u2009&lt;\u20090.001). Pairwise comparisons between T1 and T3 revealed a significant decrease in the incidence of enucleation (74% vs. 41%, p-value\u2009&lt;\u20090.001). The study also demonstrated a significant reduction in the incidence of enucleation when comparing T2 to T3 (60% vs. 41%, p-value\u2009&lt;\u20090.001). Comparing time intervals, there was no significant difference between T2 and T3 regarding the incidence of death (4% vs. 1%), but both intervals had statistically significant lower death rates compared with T1 (26%, both p-values\u2009&lt;\u20090.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study revealed that Introduction of systemic chemotherapy as mainstay of Rb treatment, has led to a significant reduction in mortality and morbidity rates. The incorporation of targeted chemotherapy has further decreased the need for enucleation, but it has not substantially impacted the mortality rate. Unfortunately, in spite of reduction trend in enucleation, systemic and targeted chemotherapy was unable to save the affected globe in nearly half of the patients, even when the malignancy was diagnosed in the earlier stages.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40942-025-00702-4","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:34:31Z","timestamp":1760700871000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Retinoblastoma survival trend: a 30-year analysis from a referral single center in Iran"],"prefix":"10.1186","volume":"11","author":[{"given":"Masood","family":"Naseripour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Aghajani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengameh","family":"Kasraei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Mirshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahad","family":"Sedaghat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parya","family":"Abdolalizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Fazel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Chaibakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"issue":"1","key":"702_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12887-023-03984-5","volume":"23","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wang Y, Zhi T, Jin M, Huang D, Ma X. Clinical characteristics, treatment and prognosis of infants with retinoblastoma: a multicenter, 10-year retrospective analysis. BMC Pediatr. 2023;23(1):229.","journal-title":"BMC Pediatr"},{"key":"702_CR2","doi-asserted-by":"publisher","first-page":"100764","DOI":"10.1016\/j.preteyeres.2019.05.005","volume":"73","author":"FL Munier","year":"2019","unstructured":"Munier FL, Beck-Popovic M, Chantada GL, Cobrinik D, Kivel\u00e4 TT, Lohmann D, et al. Conservative management of retinoblastoma: challenging orthodoxy without compromising the state of metastatic grace. Alive, with good vision and no comorbidity. Prog Retin Eye Res. 2019;73:100764.","journal-title":"Prog Retin Eye Res"},{"key":"702_CR3","doi-asserted-by":"crossref","unstructured":"Shields CL, Lally SE. Retinoblastoma. Ocular oncology. 2019:91\u20139.","DOI":"10.1007\/978-981-13-2336-2_10"},{"issue":"12","key":"702_CR4","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.ophtha.2020.05.050","volume":"127","author":"AS Tomar","year":"2020","unstructured":"Tomar AS, Finger PT, Gallie B, Mallipatna A, Kivel\u00e4 TT, Zhang C, et al. A multicenter, international collaborative study for American joint committee on cancer staging of retinoblastoma: part I: metastasis-associated mortality. Ophthalmology. 2020;127(12):1719\u201332.","journal-title":"Ophthalmology"},{"issue":"8","key":"702_CR5","first-page":"322","volume":"18","author":"HL Hilgartner","year":"1903","unstructured":"Hilgartner HL. Report of case of double glioma treated with X-Ray. Texas medical journal. (Austin Tex). 1903;18(8):322\u20133.","journal-title":"(Austin Tex)"},{"key":"702_CR6","first-page":"289","volume":"44","author":"A Kaneko","year":"1990","unstructured":"Kaneko A. Chemo-thermotherapy was successful in two cases of recurrence of intraocular retinoblastoma after irradiation. Rinsho Ganka (Jpn J Clin Ophthalmol). 1990;44:289\u201392.","journal-title":"Rinsho Ganka (Jpn J Clin Ophthalmol)"},{"issue":"8","key":"702_CR7","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.ophtha.2007.12.014","volume":"115","author":"DH Abramson","year":"2008","unstructured":"Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I\/II study of direct intraarterial (ophthalmic artery) chemotherapy with Melphalan for intraocular retinoblastoma: initial results. Ophthalmology. 2008;115(8):1398\u2013404. e1.","journal-title":"Ophthalmology"},{"issue":"6","key":"702_CR8","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/j.1442-9071.2010.02297.x","volume":"38","author":"CL Shields","year":"2010","unstructured":"Shields CL, Shields JA. Intra-arterial chemotherapy for retinoblastoma: the beginning of a long journey. Clin Exp Ophthalmol. 2010;38(6):638\u201343.","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"702_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40137-022-00312-1","volume":"10","author":"AM Rusakevich","year":"2022","unstructured":"Rusakevich AM, Schefler AC. Retinoblastoma: recent trends in diagnosis and management. Curr Surg Rep. 2022;10(4):51\u20136.","journal-title":"Curr Surg Rep"},{"issue":"16","key":"702_CR10","doi-asserted-by":"publisher","first-page":"6899","DOI":"10.7314\/APJCP.2015.16.16.6899","volume":"16","author":"P Wongmas","year":"2015","unstructured":"Wongmas P, Jetsrisuparb A, Komvilaisak P, Suwanrungruang K, Choeyprasert W, Sriplung H, et al. Incidences, trends and long term outcomes of retinoblastoma in three cancer registries, Thailand. Asian Pac J Cancer Prev. 2015;16(16):6899\u2013902.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"702_CR11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41433-021-01845-y","volume":"37","author":"O Warda","year":"2023","unstructured":"Warda O, Naeem Z, Roelofs KA, Sagoo MS, Reddy MA. Retinoblastoma and vision. Eye. 2023;37(5):797\u2013808.","journal-title":"Eye"},{"issue":"5","key":"702_CR12","doi-asserted-by":"publisher","first-page":"6318","DOI":"10.1002\/cam4.5406","volume":"12","author":"B Abdelazeem","year":"2023","unstructured":"Abdelazeem B, Abbas KS, Shehata J, El-Shahat NA, Eltaras MM, Qaddoumi I, et al. Survival trends for patients with retinoblastoma between 2000 and 2018: what has changed? Cancer Med. 2023;12(5):6318\u201324.","journal-title":"Cancer Med"},{"key":"702_CR13","unstructured":"Abramson DH, Beaverson K, Fau - Sangani P, Sangani P, Fau - Vora RA. Vora Ra Fau - Lee TC, Lee Tc Fau - Hochberg HM, Hochberg Hm Fau - Kirszrot J, Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival. (1098\u20134275 (Electronic))."},{"key":"702_CR14","unstructured":"World Health Organization. Global Initiative for Childhood Cancer WHO2018 [Available from: https:\/\/www.who.int\/initiatives\/the-global-initiative-for-childhood-cancer"},{"key":"702_CR15","unstructured":"Andreoli MT, Chau FY, Shapiro MJ, Leiderman YI. Epidemiological trends in 1452 cases of retinoblastoma from the Surveillance, Epidemiology, and End Results (SEER) registry. (1715\u20133360 (Electronic))."},{"key":"702_CR16","unstructured":"Berry Jl Fau -, Kogachi K, Kogachi K, Fau - Murphree AL, Murphree Al Fau -, Jubran R, Jubran R, Fau - Kim JW, Kim JW. A Review of Recurrent Retinoblastoma: Children\u2019s Hospital Los Angeles Classification and Treatment Guidelines. (1536\u20139617 (Electronic))."},{"key":"702_CR17","unstructured":"Shields CL, Shields JA. Diagnosis and management of retinoblastoma. (1526\u20132359 (Electronic))."},{"key":"702_CR18","unstructured":"Tamboli D, Topham A, Singh N, Singh AD, Retinoblastoma. A SEER Dataset Evaluation for Treatment Patterns, Survival, and Second Malignant Neoplasms. (1879\u20131891 (Electronic))."},{"key":"702_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1146\/annurev-med-061312-123455","volume":"65","author":"DH Abramson","year":"2014","unstructured":"Abramson DH. Retinoblastoma: saving life with vision. Annu Rev Med. 2014;65:171\u201384.","journal-title":"Annu Rev Med"},{"key":"702_CR20","unstructured":"Fabian ID, Onadim Z, Karaa E, Duncan C, Chowdhury T, Scheimberg I et al. Manage Retinoblastoma. (1476\u20135594 (Electronic))."},{"issue":"1","key":"702_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41433-018-0244-7","volume":"33","author":"M Jain","year":"2019","unstructured":"Jain M, Rojanaporn D, Chawla B, Sundar G, Gopal L, Khetan V. Retinoblastoma Asia Eye (Lond). 2019;33(1):87\u201396.","journal-title":"Retinoblastoma Asia Eye (Lond)"},{"issue":"1","key":"702_CR22","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1177\/11206721221093018","volume":"33","author":"M Naseripour","year":"2023","unstructured":"Naseripour M, Sedaghat A, Mirshahi R, Abdolalizadeh P, Koushki A, Faranoush M, et al. Targeted chemotherapy in retinoblastoma: A step forward from patient survival to Globe survival. Eur J Ophthalmol. 2023;33(1):574\u201386.","journal-title":"Eur J Ophthalmol"},{"issue":"8","key":"702_CR23","doi-asserted-by":"publisher","first-page":"e1128","DOI":"10.1016\/S2214-109X(22)00250-9","volume":"10","author":"The Global Retinoblastoma","year":"2022","unstructured":"The Global Retinoblastoma. Outcome study: a prospective, cluster-based analysis of 4064 patients from 149 countries. Lancet Global Health. 2022;10(8):e1128\u201340.","journal-title":"Lancet Global Health"},{"issue":"3","key":"702_CR24","doi-asserted-by":"publisher","first-page":"e380","DOI":"10.1016\/S2214-109X(21)00555-6","volume":"10","author":"ES Wong","year":"2022","unstructured":"Wong ES, Choy RW, Zhang Y, Chu WK, Chen LJ, Pang CP, et al. Global retinoblastoma survival and Globe preservation: a systematic review and meta-analysis of associations with socioeconomic and health-care factors. Lancet Global Health. 2022;10(3):e380\u20139.","journal-title":"Lancet Global Health"},{"key":"702_CR25","unstructured":"NASERIPOUR M, GHASEMI FK, Bakhtiari P, Vosoughi P, ARIAN F. Retinoblastoma survival in iran: 10 years experience of a referral center. J Curr Ophthalmol. 2009."},{"issue":"1","key":"702_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1136\/bjo.2008.139410","volume":"93","author":"M Naseripour","year":"2009","unstructured":"Naseripour M, Nazari H, Bakhtiari P, Modarres-zadeh M, Vosough P, Ausari M. Retinoblastoma in iran: outcomes in terms of patients\u2019 survival and Globe survival. Br J Ophthalmol. 2009;93(1):28\u201332.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"702_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/bjo.2008.138750","volume":"93","author":"E Broaddus","year":"2009","unstructured":"Broaddus E, Topham A, Singh AD. Incidence of retinoblastoma in the USA: 1975\u20132004. Br J Ophthalmol. 2009;93(1):21\u20133.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"702_CR28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3928\/01913913-20171116-03","volume":"55","author":"AG Fernandes","year":"2018","unstructured":"Fernandes AG, Pollock BD, Rabito FA. Retinoblastoma in the united states: A 40-Year incidence and survival analysis. J Pediatr Ophthalmol Strabismus. 2018;55(3):182\u20138.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"1","key":"702_CR29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/bjo.2008.139626","volume":"93","author":"A MacCarthy","year":"2009","unstructured":"MacCarthy A, Birch JM, Draper GJ, Hungerford JL, Kingston JE, Kroll ME, et al. Retinoblastoma: treatment and survival in great Britain 1963 to 2002. Br J Ophthalmol. 2009;93(1):38\u20139.","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"702_CR30","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1136\/bjophthalmol-2016-309298","volume":"101","author":"FL Munier","year":"2017","unstructured":"Munier FL, Mosimann P, Puccinelli F, Gaillard MC, Stathopoulos C, Houghton S, et al. First-line intra-arterial versus intravenous chemotherapy in unilateral sporadic group D retinoblastoma: evidence of better visual outcomes, ocular survival and shorter time to success with intra-arterial delivery from retrospective review of 20\u2005years of treatment. Br J Ophthalmol. 2017;101(8):1086\u201393.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"702_CR31","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1001\/jamaoncol.2019.6716","volume":"6","author":"ID Fabian","year":"2020","unstructured":"Fabian ID, Abdallah E, Abdullahi SU, Abdulqader RA, Adamou Boubacar S, Ademola-Popoola DS, et al. Global retinoblastoma presentation and analysis by National income level. JAMA Oncol. 2020;6(5):685\u201395.","journal-title":"JAMA Oncol"},{"issue":"9","key":"702_CR32","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1136\/bjo.2008.150292","volume":"93","author":"T Kivel\u00e4","year":"2009","unstructured":"Kivel\u00e4 T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93(9):1129\u201331.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"702_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00347-014-3123-z","volume":"112","author":"EN Gichigo","year":"2015","unstructured":"Gichigo EN, Kariuki-Wanyoike MM, Kimani K, Nentwich MM. [Retinoblastoma in kenya: survival and prognostic factors]. Ophthalmologe. 2015;112(3):255\u201360.","journal-title":"Ophthalmologe"},{"issue":"3","key":"702_CR34","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000481508","volume":"4","author":"S Goolam","year":"2018","unstructured":"Goolam S, Kana H, Welsh N, Wainwright L, Poole J, Mayet I. A 20-Year retrospective review of retinoblastoma at two tertiary academic hospitals in johannesburg, South Africa. Ocul Oncol Pathol. 2018;4(3):170\u20135.","journal-title":"Ocul Oncol Pathol"},{"issue":"2","key":"702_CR35","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/IAE.0000000000001962","volume":"39","author":"S Kaliki","year":"2019","unstructured":"Kaliki S, Patel A, Iram S, Ramappa G, Mohamed A, Palkonda VAR. RETINOBLASTOMA IN INDIA: clinical presentation and outcome in 1,457 patients (2,074 Eyes). Retina. 2019;39(2):379\u201391.","journal-title":"Retina"},{"issue":"1","key":"702_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000477408","volume":"4","author":"U Singh","year":"2017","unstructured":"Singh U, Katoch D, Kaur S, Dogra MR, Bansal D, Kapoor R. Retinoblastoma: A Sixteen-Year review of the presentation, treatment, and outcome from a tertiary care Institute in Northern India. Ocul Oncol Pathol. 2017;4(1):23\u201332.","journal-title":"Ocul Oncol Pathol"},{"issue":"5","key":"702_CR37","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0021-5155(02)00546-4","volume":"46","author":"LY Kao","year":"2002","unstructured":"Kao LY, Su WW, Lin YW. Retinoblastoma in taiwan: survival and clinical characteristics 1978\u20132000. Jpn J Ophthalmol. 2002;46(5):577\u201380.","journal-title":"Jpn J Ophthalmol"},{"issue":"11","key":"702_CR38","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1136\/bjo.2009.168062","volume":"94","author":"S Canturk","year":"2010","unstructured":"Canturk S, Qaddoumi I, Khetan V, Ma Z, Furmanchuk A, Antoneli CB, et al. Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators. Br J Ophthalmol. 2010;94(11):1432\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"702_CR39","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/bjophthalmol-2015-306672","volume":"100","author":"B Chawla","year":"2016","unstructured":"Chawla B, Hasan F, Azad R, Seth R, Upadhyay AD, Pathy S, et al. Clinical presentation and survival of retinoblastoma in Indian children. Br J Ophthalmol. 2016;100(2):172\u20138.","journal-title":"Br J Ophthalmol"},{"key":"702_CR40","doi-asserted-by":"crossref","unstructured":"Kumaramanickavel G, Retinoblastoma. An update on clinical, genetic counseling, epidemiology and molecular tumor biology. BoD\u2013Books on Demand; 2012.","DOI":"10.5772\/1301"},{"key":"702_CR41","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.2147\/OTT.S370878","volume":"15","author":"M Naseripour","year":"2022","unstructured":"Naseripour M, Mirshahi R, Kasraei H, Sedaghat A, Azimi F. Spotlight on targeted chemotherapy in retinoblastoma: safety, efficacy, and patient outcomes. OncoTargets Therapy. 2022;15:1545\u201361.","journal-title":"OncoTargets Therapy"},{"issue":"14","key":"702_CR42","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1002\/cncr.25854","volume":"117","author":"XL Du","year":"2011","unstructured":"Du XL, Lin CC, Johnson NJ, Altekruse S. Effects of individual-level socioeconomic factors on Racial disparities in cancer treatment and survival: findings from the National longitudinal mortality study, 1979\u20132003. Cancer. 2011;117(14):3242\u201351.","journal-title":"Cancer"},{"issue":"20","key":"702_CR43","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1001\/jama.291.20.2471","volume":"291","author":"SC Howard","year":"2004","unstructured":"Howard SC, Pedrosa M, Lins M, Pedrosa A, Pui CH, Ribeiro RC, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA. 2004;291(20):2471\u20135.","journal-title":"JAMA"},{"issue":"3","key":"702_CR44","doi-asserted-by":"publisher","first-page":"e763","DOI":"10.1542\/peds.2008-0518","volume":"122","author":"C Rodriguez-Galindo","year":"2008","unstructured":"Rodriguez-Galindo C, Wilson MW, Chantada G, Fu L, Qaddoumi I, Antoneli C, et al. Retinoblastoma: one world, one vision. Pediatrics. 2008;122(3):e763\u201370.","journal-title":"Pediatrics"},{"issue":"10","key":"702_CR45","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1136\/bjophthalmol-2020-316613","volume":"105","author":"ID Fabian","year":"2021","unstructured":"Fabian ID, Stacey AW, Foster A, Kivel\u00e4 TT, Munier FL, Keren-Froim N, et al. Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries. Br J Ophthalmol. 2021;105(10):1435\u201343.","journal-title":"Br J Ophthalmol"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00702-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-025-00702-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00702-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:34:34Z","timestamp":1760700874000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-025-00702-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["702"],"URL":"https:\/\/doi.org\/10.1186\/s40942-025-00702-4","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocol was approved by the medical ethics committee of Iran University of Medical Sciences (IR.IUMS.FMD.REC.1398.292) and the study adhered to the ethical principles outlined in the Declaration of Helsinki. The sentence was mentioned in the \u2018Materials and Methods\u2019 section.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All data was extracted after written informed consent was obtained from children\u2019s parents. Also Informed consent was written to allow us to publish the data. The sentence was mentioned in the \u2018Materials and Methods\u2019 section.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"113"}}